[YMAB] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -1,171.07%
YoY- 82.08%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 23,363 20,454 20,751 20,251 31,447 12,537 10,797 67.06%
PBT -793 -7,560 -6,123 -6,390 1,157 -27,526 -41,131 -92.75%
Tax 195 187 179 -1,293 1,558 1,509 1,186 -69.88%
NP -988 -7,747 -6,302 -5,097 -401 -29,035 -42,317 -91.77%
Tax Rate - - - - -134.66% - - -
Total Cost 24,351 28,201 27,053 25,348 31,848 41,572 53,114 -40.45%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -4.23 -37.88 -30.37 -25.17 -1.28 -231.59 -391.93 -95.07%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.02 -0.18 -0.14 -0.12 -0.01 -0.66 -0.97 -92.42%
EPS Diluted -0.02 -0.18 -0.14 -0.12 -0.01 -0.66 -0.97 -92.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.